Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure

被引:0
|
作者
Felix Hofer
Niema Kazem
Bernhard Richter
Patrick Sulzgruber
Ronny Schweitzer
Ulrike Pailer
Andreas Hammer
Lorenz Koller
Christian Hengstenberg
Alexander Niessner
机构
[1] Medical University of Vienna,Department of Internal Medicine II, Division of Cardiology
[2] Vienna Healthcare Group,undefined
来源
关键词
SGLT2i; Diabetes mellitus; Heart failure; Prescription patterns;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:497 / 504
页数:7
相关论文
共 50 条
  • [21] Sodium-glucose cotransporter 2 inhibitors for the management of heart failure
    Nouel, Ana
    Winter, Jose Luis
    Sepulveda, Luis
    REVISTA MEDICA DE CHILE, 2022, 150 (12) : 1647 - 1654
  • [22] Heart failure prevention with sodium-glucose cotransporter 2 inhibitors
    Khan, Muhammad Shahzeb
    Butler, Javed
    JOURNAL OF DIABETES, 2019, 11 (07) : 601 - 604
  • [23] SODIUM-GLUCOSE COTRANSPORTER2 INHIBITORS IN HEART FAILURE
    Kazmierski, Wojciech
    Jurek, Jakub
    Lis, Paulina
    Lis, Anna
    Ziobro, Anna
    Ziomek, Mateusz
    Camlet, Katarzyna
    Kocur, Kinga
    PROSPECTS IN PHARMACEUTICAL SCIENCES, 2024, 22 (03): : 225 - 232
  • [24] Mechanisms of Sodium-glucose Cotransporter 2 Inhibitors in Heart Failure
    Wei, Jiangjun
    Du, Jianlin
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2023, 8 (01)
  • [25] Effects of Sodium-Glucose Cotransporter Inhibitor Use in Type 2 Diabetes Mellitus Patients With Heart Failure
    Choday, Silpa
    Ravi, Niriksha
    Parisapogu, Anusha
    Ojinna, Blessing T.
    Sherpa, Mingma L.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [26] Real-Life Individual Comparison of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure and Diabetes Mellitus
    Yilmaz, Mehmet Birhan
    Celik, Ahmet
    Colluoglu, Tugce
    Sahin, Anil
    Ural, Dilek
    Kanik, Arzu
    Ata, Naim
    Ulgu, Mustafa Mahir
    Birinci, Suayip
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (02) : 277 - 286
  • [27] Effect of Sodium-Glucose Cotransporter Inhibitors on Major Adverse Cardiovascular Events and Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus and Atrial Fibrillation
    Kwon, Chang Hee
    Kim, Ye-Jee
    Kim, Min-Ju
    Cha, Myung-Jin
    Cho, Min Soo
    Nam, Gi-Byoung
    Choi, Kee-Joon
    Kim, Jun
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 178 : 35 - 42
  • [28] Diuretic effects of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and heart failure
    Takeuchi, Tetsushiro
    Dohi, Kaoru
    Omori, Taku
    Moriwaki, Keishi
    Sato, Yuichi
    Nakamori, Shiro
    Fujimoto, Naoki
    Fujii, Eitaro
    Yamada, Norikazu
    Ito, Masaaki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 : 1 - 3
  • [29] Sodium-Glucose Cotransporter-2 Inhibitors as Treatment for Diabetes Mellitus Type 2 in a Cohort of Patients Who Suffer Heart Failure
    Morgado Garcia De Polavieja, Jose Ignacio
    Roa-Garrido, Jessica
    Rodriguez Ortega, Pilar
    Diaz Fernandez, Jose Francisco
    DIABETES, 2017, 66 : A632 - A632
  • [30] The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure, Regardless of Diabetes Status: Focus on Cardiovascular Disease
    Ferrari, Filipe
    Martins, Vitor M.
    Scheffel, Rafael S.
    da Silveira, Anderson D.
    Motta, Marcelo Trotte
    Moriguchi, Emilio H.
    Santos, Raul D.
    Stein, Ricardo
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (10) : 1267 - 1275